{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:49:01Z","timestamp":1765356541094,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009946","name":"Allergopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"name":"GSK"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.anai.2019.04.011","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T19:52:53Z","timestamp":1555703573000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis"],"prefix":"10.1016","volume":"123","author":[{"given":"Michael","family":"Gerstlauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Szepfalusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bob","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"de Blic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 86","key":"10.1016\/j.anai.2019.04.011_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib2","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.5415\/apallergy.2018.8.e7","article-title":"The International Study of the Allergic Rhinitis Survey: outcomes from 4 geographical regions","volume":"8","author":"Passali","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1399-3038.2007.00601.x","article-title":"Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood","volume":"19","author":"Bjorksten","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1398-9995.2008.01884.x","article-title":"Global map of the prevalence of symptoms of rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three","volume":"64","author":"Ait-Khaled","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib5","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaci.2010.12.1106","article-title":"Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006","volume":"127","author":"Salo","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ebiom.2017.11.009","article-title":"Detection of IgE reactivity to a handful of allergen molecules in early childhood predicts respiratory allergy in adolescence","volume":"26","author":"Wickman","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.anai.2019.04.011_bib8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/1744666X.2017.1277142","article-title":"Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy","volume":"13","author":"Wahn","year":"2017","journal-title":"Exp Rev Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000353344","article-title":"Patterns of sensitization to inhalant and food allergens: findings from the German Health Interview and Examination Survey for Children and Adolescents","volume":"162","author":"Schmitz","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib10","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1001\/archinte.166.16.1744","article-title":"Allergic rhinitis and its consequences on quality of sleep: an unexplored area","volume":"166","author":"Leger","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.anai.2019.04.011_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2500\/aap.2009.30.3230","article-title":"Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey","volume":"30","author":"Meltzer","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.anai.2019.04.011_bib12","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.jaci.2004.08.044","article-title":"The correlation between allergic rhinitis and sleep disturbance","volume":"114","author":"Craig","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib13","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaci.2009.05.013","article-title":"Burden of allergic rhinitis: results from the Pediatric Allergies in America survey","volume":"124","author":"Meltzer","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2007.03.034","article-title":"Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study","volume":"120","author":"Walker","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib15","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(11)60130-X","article-title":"Allergic rhinitis","volume":"378","author":"Greiner","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.anai.2019.04.011_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOP.0000000000000120","article-title":"New insights into the allergic march","volume":"26","author":"Shaker","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.anai.2019.04.011_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2017.08.012","article-title":"Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update","volume":"119","author":"Dykewicz","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib18","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.anai.2010.10.014","article-title":"The economic impact of allergic rhinitis and current guidelines for treatment","volume":"106","author":"Meltzer","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib19","first-page":"S1","article-title":"Clinical practice guideline: allergic rhinitis","volume":"152","author":"Seidman","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anai.2019.04.011_bib20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1067\/mai.2000.110098","article-title":"Development of seasonal allergic rhinitis during the first 7 years of life","volume":"106","author":"Kulig","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5604\/01.3001.0011.8057","article-title":"Treatment strategy of allergic rhinitis in the face of modern world threats","volume":"72","author":"Rapiejko","year":"2018","journal-title":"Otolaryngol Pol"},{"key":"10.1016\/j.anai.2019.04.011_bib22","first-page":"1","article-title":"Local and systemic safety of intranasal corticosteroids","volume":"22","author":"Sastre","year":"2012","journal-title":"J\u00a0Invest Allergol Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1081-1206(10)60322-5","article-title":"Effect on growth of long-term treatment with intranasal triamcinolone acetonide aqueous in children with allergic rhinitis","volume":"101","author":"Skoner","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.anai.2019.04.011_bib25","first-page":"CD001936","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anai.2019.04.011_bib26","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.2013-0343","article-title":"Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review","volume":"131","author":"Kim","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.anai.2019.04.011_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1824-7288-35-31","article-title":"Sublingual immunotherapy in children: facts and needs","volume":"35","author":"Marseglia","year":"2009","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.anai.2019.04.011_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaip.2013.03.012","article-title":"Current and future directions in pediatric allergic rhinitis","volume":"1","author":"Gentile","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.04.011_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2018.03.008","article-title":"The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases","volume":"67","author":"Nolte","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.anai.2019.04.011_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib33","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jaci.2008.10.009","article-title":"Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis","volume":"123","author":"Wahn","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000095994","article-title":"Standardization of an ash (Fraxinus excelsior) pollen allergen extract","volume":"142","author":"Hrabina","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/ACI.0b013e328332b8df","article-title":"Evidence of adherence to allergen-specific immunotherapy","volume":"9","author":"Senna","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1513\/AnnalsATS.201311-405PS","article-title":"The global burden of respiratory disease","volume":"11","author":"Ferkol","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.anai.2019.04.011_bib37","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2013.01.049","article-title":"Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology\/European Academy of Allergy and Clinical Immunology\/PRACTALL consensus report","volume":"131","author":"Burks","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib39","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.jaip.2017.04.020","article-title":"Safety review of 5-grass pollen tablet from pooled data of clinical trials","volume":"5","author":"Casale","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.anai.2019.04.011_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile","volume":"67","author":"Calderon","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jaci.2007.07.046","article-title":"Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis","volume":"120","author":"Didier","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib42","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1399-3038.2010.01050.x","article-title":"Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents","volume":"21","author":"Halken","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1399-3038.2007.00556.x","article-title":"Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children","volume":"18","author":"Ibanez","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib45","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/pai.12298","article-title":"An observational, real-life safety study of a 5-grass pollen sublingual tablet in children and adolescents","volume":"25","author":"Eberle","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib46","doi-asserted-by":"crossref","first-page":"584291","DOI":"10.1155\/2015\/584291","article-title":"Sublingual immunotherapy with a five-grass pollen tablet in adult patients with allergic rhinitis: an open, prospective, noninterventional, multicenter study","volume":"2015","author":"Pfaar","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.anai.2019.04.011_bib47","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s12325-017-0535-6","article-title":"Management of grass pollen allergy with 5-grass pollen tablet: results of a 2-year real-life study","volume":"34","author":"Shah-Hosseini","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.anai.2019.04.011_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13223-018-0262-9","article-title":"An observational cohort study of the\u00a0use of five-grass-pollen extract sublingual immunotherapy during\u00a0the 2015 pollen season in France","volume":"14","author":"Blin","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.anai.2019.04.011_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13601-016-0097-8","article-title":"Tolerability of the SQ-standardised grass sublingual immunotherapy tablet in patients treated with concomitant allergy immunotherapy: a non-interventional observational study","volume":"6","author":"Reiber","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.anai.2019.04.011_bib50","first-page":"5","article-title":"Treatment with the SQ-standardised grass allergy immunotherapy tablet is well tolerated in children, adolescents and adults in real life application-a non-interventional observational study","volume":"4","author":"Gronke","year":"2013","journal-title":"J\u00a0Allergy Ther"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619302959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120619302959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:22:07Z","timestamp":1761052927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120619302959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1081120619302959"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2019.04.011","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2019.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of American College of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}